Linde stock faces valuation test after mixed third quarter

Linde's latest quarterly update has left investors balancing operational growth against valuation risk. In an analysis published on Monday, November 9, 2026, Simply Wall St said Linde reported higher third-quarter sales but lower quarterly net income. Revenue and profit for the first nine months were both above the prior-year period.

Linde stock traded at 463.60 euros on Lang & Schwarz at 12:10 CET on Tuesday, November 10, 2026, 0.17 percent below the Xetra close of Monday, November 9, at 464.40 euros. The comparison uses the previous Xetra session because the current trading day was still underway.

Growth Supports The Investment Case

The company remains positioned around industrial gases and engineering services for healthcare, manufacturing, chemicals, food and beverage, electronics and energy customers. Linde's investor-relations page describes 2025 sales of 34 billion US dollars and highlights its role in gas processing, decarbonization and large clean-energy projects.

Simply Wall St pointed to commercial space, electronics and clean hydrogen as potential sources of higher-value growth. The analysis said Linde has a stated path to more than 1 billion US dollars in space revenue by 2030, while hydrogen and carbon-capture projects could improve the revenue mix if projects reach operation as planned.

Premium Multiple Raises The Stakes

The valuation picture is less comfortable. Simply Wall St's analyst-led narrative placed fair value at 544.40 US dollars, or 5.4 percent above the last close cited in the analysis. At the same time, Linde's price-to-earnings ratio was 33.8, compared with 23.4 for the US chemicals industry and a 22.8 fair ratio in the analysis.

That spread gives investors a clear execution test: Linde must convert its project pipeline and growth initiatives into durable earnings while containing weakness in European industrial demand and margin pressure in its US homecare business. The recent market response has been cautious, with Simply Wall St reporting a 1.2 percent daily decline and a 0.9 percent weekly decline in the period it reviewed.

Conference Keeps Investors Focused

Linde's investor-relations calendar lists the Morgan Stanley Global Chemicals and Agriculture Conference for Tuesday, November 10, 2026. Further investor attention is likely to center on project execution, regional demand and the company's ability to protect margins as growth investments increase.

The broader US market context is available through the S&P 500.

More news and analysis are available on More news and analyses on Linde stock.